Epidemiological and Genetic Diversity of Staphylococcus aureus Causing Bloodstream Infection in Shanghai, 2009-2011

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Chen, Xu ^a   Wang, Wen Kui ^a   Han, Li Zhong ^a   Liu, Ying ^a   Zhang, Hong ^b   Tang, Jin ^b   Liu, Qing Zhong ^b   Huangfu, Yu Chan ^a   Ni, Yu Xing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CEFOXITIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; OXACILLIN; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHINA; DRUG EFFICACY; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRACTICE GUIDELINE; STAPHYLOCOCCAL CASSETTE CHROMOSOMEMEC TYPING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIN GENE;

ALLELES; BACTEREMIA; BACTERIAL TOXINS; CHINA; GENETIC VARIATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84883652551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072811     Document Type: Article

References (28)

1. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, et al. (2005) Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 5: 653-663.
2. Salgado CD, Farr BM, Calfee DP, (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36: 131-139.
3. Morell EA, Balkin DM, (2010) Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med 83: 223-233.
4. Zurita J, Mejia C, Guzman-Blanco M, (2010) Diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus in Latin America. Braz J Infect Dis 14Suppl 2: S97-106.
5. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
6. Wang WY, Chiueh TS, Sun JR, Tsao SM, Lu JJ, (2012) Molecular Typing and Phenotype Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Blood in Taiwan. PLoS One 7: e30394.
7. Rodriguez-Noriega E, Seas C, Guzman-Blanco M, Mejia C, Alvarez C, et al. (2010) Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis 14: e560-566.
8. Mehndiratta PL, Bhalla P, (2012) Typing of Methicillin resistant Staphylococcus aureus: A technical review. Indian J Med Microbiol 30: 16-23.
9. Han LZ, Ho PL, Ni YX, Zhang H, Jiang YQ, et al. (2010) Panton-Valentine leukocidin-positive MRSA, Shanghai. Emerg Infect Dis 16: 731-733.
10. Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, et al. (2012) Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl) 125: 226-229.
11. Song Y, Du X, Tian Y, Ruan F, Lv Y, et al. (2011) Molecular characterization of Staphylococcus aureus collected from 2004 to 2010 in patients with bloodstream infection. Chin J Lab Med 34: 705-711.
12. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, et al. (2012) Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 18: 862-869.
13. Otter JA, French GL, (2012) Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 81: 143-148.
14. Chen X, Yang HH, Huangfu YC, Wang WK, Liu Y, et al. (2012) Molecular epidemiologic analysis of Staphylococcus aureus isolated from four burn centers. Burns 38: 738-742.
15. Franklin RC, Matthew AW, Jeff A, Michael ND, George ME, et al. (2012) Performance Standards for Antimicrobial Susceptibility Testing. Twenty-second Informational Supplement, M100-S22. U.S.A.: Wayne.
16. Perez-Roth E, Claverie-Martin F, Villar J, Mendez-Alvarez S, (2001) Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. J Clin Microbiol 39: 4037-4041.
17. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, et al. (1999) Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 43: 1062-1066.
18. Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, et al. (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41: 5442-5448.
19. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, et al. (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70: 631-641.
20. Yamada K, Yanagihara K, Hara Y, Araki N, Harada Y, et al. (2011) Clinical features of bacteremia caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital. Tohoku J Exp Med 224: 61-67.
21. Albur MS, Bowker K, Weir I, MacGowan A, (2012) Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 31: 295-301.
22. Kim JS, Holtom P, Vigen C, (2011) Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 39: 640-646.
23. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, et al. (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52: e18-55.
24. Shore AC, Brennan OM, Ehricht R, Monecke S, Schwarz S, et al. (2010) Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate. Antimicrob Agents Chemother 54: 4978-4984.
25. Locke JB, Morales G, Hilgers M, G CK, Rahawi S, et al. (2010) Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3. Antimicrob Agents Chemother 54: 5352-5355.
26. Wang Y, Zhang W, Wang J, Wu C, Shen Z, et al. (2012) Distribution of the multidrug resistance gene cfr in Staphylococcus species isolates from swine farms in China. Antimicrob Agents Chemother 56: 1485-1490.
27. Kuo SC, Chiang MC, Lee WS, Chen LY, Wu HS, et al. (2012) Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Int J Antimicrob Agents 39: 22-26.
28. Li M, Du X, Villaruz AE, Diep BA, Wang D, et al. (2012) MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med 18: 816-819.